275 related articles for article (PubMed ID: 26669864)
1. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM
Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer.
Yun SI; Kim HH; Yoon JH; Park WS; Hahn MJ; Kim HC; Chung CH; Kim KK
Mol Oncol; 2015 Nov; 9(9):1834-51. PubMed ID: 26189775
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
Li T; Yan B; Ma Y; Weng J; Yang S; Zhao N; Wang X; Sun X
Cell Death Dis; 2018 Feb; 9(2):148. PubMed ID: 29396555
[TBL] [Abstract][Full Text] [Related]
4. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X
Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
8. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I.
Wang L; Zhao W; Zhang M; Wang P; Zhao K; Zhao X; Yang S; Gao C
J Virol; 2013 Apr; 87(8):4507-15. PubMed ID: 23388719
[TBL] [Abstract][Full Text] [Related]
9. A Selective Inhibitor of Ubiquitin-Specific Protease 4 Suppresses Colorectal Cancer Progression by Regulating β-Catenin Signaling.
Nguyen HH; Kim T; Nguyen T; Hahn MJ; Yun SI; Kim KK
Cell Physiol Biochem; 2019; 53(1):157-171. PubMed ID: 31251006
[TBL] [Abstract][Full Text] [Related]
10. USP4 promotes invasion of breast cancer cells via Relaxin/TGF-β1/Smad2/MMP-9 signal.
Cao WH; Liu XP; Meng SL; Gao YW; Wang Y; Ma ZL; Wang XG; Wang HB
Eur Rev Med Pharmacol Sci; 2016; 20(6):1115-22. PubMed ID: 27049265
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma.
Hou X; Wang L; Zhang L; Pan X; Zhao W
FEBS Lett; 2013 Feb; 587(4):311-6. PubMed ID: 23313255
[TBL] [Abstract][Full Text] [Related]
12. A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.
Geng N; Li Y; Zhang W; Wang F; Wang X; Jin Z; Xing Y; Li D; Zhang H; Li Y; Li X; Cheng M; Jin F; Li F
Int J Cancer; 2020 Feb; 146(4):1139-1151. PubMed ID: 31219614
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits the development of colorectal cancer via regulating the USP4/LAMP3 pathway.
Wei H; Li X; Liu F; Li Y; Luo B; Huang X; Chen H; Wen B; Ma P
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1749-1762. PubMed ID: 37728623
[TBL] [Abstract][Full Text] [Related]
14. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4.
Li Y; Jiang D; Zhang Q; Liu X; Cai Z
Int J Mol Med; 2016 Sep; 38(3):803-11. PubMed ID: 27430936
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9.
Choi BJ; Park SA; Lee SY; Cha YN; Surh YJ
Sci Rep; 2017 Nov; 7(1):15918. PubMed ID: 29162839
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinoma.
Hwang SJ; Lee HW; Kim HR; Lee H; Shin CH; Yun SI; Lee DH; Kim DH; Kim KK; Joo KM; Kim HH
Sci Rep; 2016 Feb; 6():21596. PubMed ID: 26883469
[TBL] [Abstract][Full Text] [Related]
19. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
20. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
